|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-2-27
|
|
pubmed:abstractText |
Peptic ulcer bleeding remains a disease with considerable morbidity and mortality. Epinephrine is the most widely used endoscopic injection agent, but bleeding recurs in 20% of high-risk cases. Fibrin glue might be an ideal injection agent, based on its physiologic properties, despite its demanding injection technique and high cost. The aim of this study was to determine whether the injection of fibrin glue in combination with epinephrine improves outcome for patients at high risk of recurrent bleeding.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0016-5107
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
348-53
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11868007-Adult,
pubmed-meshheading:11868007-Aged,
pubmed-meshheading:11868007-Aged, 80 and over,
pubmed-meshheading:11868007-Combined Modality Therapy,
pubmed-meshheading:11868007-Endoscopy, Gastrointestinal,
pubmed-meshheading:11868007-Epinephrine,
pubmed-meshheading:11868007-Female,
pubmed-meshheading:11868007-Fibrin Tissue Adhesive,
pubmed-meshheading:11868007-Hemostatics,
pubmed-meshheading:11868007-Humans,
pubmed-meshheading:11868007-Injections,
pubmed-meshheading:11868007-Male,
pubmed-meshheading:11868007-Middle Aged,
pubmed-meshheading:11868007-Peptic Ulcer Hemorrhage,
pubmed-meshheading:11868007-Prospective Studies,
pubmed-meshheading:11868007-Recurrence,
pubmed-meshheading:11868007-Treatment Outcome,
pubmed-meshheading:11868007-Vasoconstrictor Agents
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial.
|
|
pubmed:affiliation |
Department of Gastroenterology, Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
